Remedy Entertainment's newly appointed CEO Jean-Charles Gaudechon has acknowledged that two of the studio's flagship franchises failed to reach their commercial potential, signaling a shift in strategy aimed at expanding their audience beyond core fans.
Gaudechon, who took the helm in March after a career stint at EA focused on FIFA for PC and mobile platforms, told The Game Business that Alan Wake and Control "should have sold more." The candid assessment arrives as Remedy grapples with a track record of critical acclaim that hasn't consistently translated to blockbuster sales.
The studio's recent output tells that story. Control's sequel took more than a year to generate profit, while the multiplayer experiment FBC: Firebreak underperformed expectations. Work on remakes of Max Payne and Max Payne 2 stalled after their announcement four years ago, and Remedy's campaign for the Korean shooter CrossfireX drew poor reviews.
Yet Gaudechon's appointment stirred concern among longtime fans wary of an outsider reshaping the studio's creative identity. His background in sports titles and mobile games seemed at odds with Remedy's reputation for offbeat, narrative-driven single-player experiences. When news of his hiring broke, messages flooded in from industry peers and close contacts offering congratulations with pointed caveats: "Don't f*** it up."
Gaudechon said he understood that devotion and intended to honor it. "Remedy is one of the few studios which is genuinely supported by players," he told The Game Business. "When I was announced, the last line was always: 'We love Remedy so much. Don't f*** it up.' That shows you how much people love Remedy."
His solution hinges on expanding reach without compromising the studio's "one-of-a-kind" creative vision. Remedy inked a strategic partnership with Annapurna Interactive in 2024 to develop television and film adaptations of its properties, a move Gaudechon views as essential infrastructure for growing the franchises beyond gaming audiences.
"Control, Alan Wake, etc. could give a lot more," Gaudechon said. "There's a vision on thinking bigger for some of these IPs, which need to find its audience much, much further than the current audience." He framed the effort as maximizing existing properties before chasing new ones. "First of all, maximize the potential of the ones we have, because they're incredible. And cross-media is going to help us do that."
In the near term, Remedy is banking on Control Resonant, the sequel to 2019's well-received Control title, slated for release sometime this year. Early impressions from gameplay previews have highlighted aggressive, fast-paced combat that marks a departure from its predecessor's more deliberate pace.
Whether Gaudechon's push for franchise expansion and broader audience development can reverse the studio's commercial trajectory remains uncertain. The strategy represents a gamble that protecting Remedy's identity while thinking bigger about its properties will pay off.
Author Emily Chen: "Gaudechon's got a tough needle to thread here, but his willingness to diagnose the problem before diving into solutions is refreshing in an industry that often mistakes creative pedigree for commercial inevitability."
Comments